PriceTargets.com logo

Premier - PINC Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $25.15
  • Forecasted Upside: 19.48%
  • Number of Analysts: 12
  • Breakdown:
  • 1 Sell Ratings
  • 9 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$21.05 As of 04/19/2024 11:23 AM ET
▲ +0.26 (1.25%)

This chart shows the closing price for PINC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Premier Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PINC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PINC

Analyst Price Target is $25.15
▲ +19.48% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Premier in the last 3 months. The average price target is $25.15, with a high forecast of $30.00 and a low forecast of $21.00. The average price target represents a 19.48% upside from the last price of $21.05.

This chart shows the closing price for PINC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 12 investment analysts is to hold stock in Premier. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 9 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/26/2024Leerink PartnrsReiterated RatingMarket PerformLow
2/26/2024SVB LeerinkInitiated CoverageMarket Perform$22.50Low
1/3/2024BarclaysInitiated CoverageEqual Weight$22.00Low
11/13/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$26.00 ➝ $21.00Low
11/9/2023BenchmarkLower TargetBuy ➝ Buy$32.00 ➝ $30.00Low
8/24/2023Robert W. BairdLower TargetNeutral ➝ Neutral$30.00 ➝ $24.00Low
8/24/2023Credit Suisse GroupLower TargetNeutral ➝ Neutral$33.00 ➝ $25.00Low
8/23/2023BenchmarkLower TargetBuy ➝ Buy$37.00 ➝ $32.00Low
8/23/2023UBS GroupLower TargetNeutral ➝ Neutral$29.00 ➝ $26.00Low
8/23/2023Canaccord Genuity GroupLower TargetBuy ➝ Buy$38.00 ➝ $30.00Low
8/23/2023Bank of AmericaLower TargetUnderperform ➝ Underperform$31.00 ➝ $26.00Low
8/23/2023Piper SandlerDowngradeOverweight ➝ Neutral$44.00 ➝ $25.00Low
6/15/2023Robert W. BairdInitiated CoveragePositiveLow
5/3/2023BenchmarkLower Target$46.00 ➝ $37.00Low
5/3/2023BarclaysLower Target$31.00 ➝ $26.00Low
5/3/2023Robert W. BairdDowngradeOutperform ➝ Neutral$43.00 ➝ $30.00N/A
5/2/2023Raymond JamesDowngradeOutperform ➝ Market PerformLow
4/18/2023Robert W. BairdBoost Target$42.00 ➝ $43.00Low
2/8/2023SVB LeerinkLower TargetOutperform$46.00 ➝ $42.00Low
1/27/2023Credit Suisse GroupUpgradeUnderperform ➝ Neutral$38.00Low
11/18/2022JPMorgan Chase & Co.Lower TargetNeutral$41.00 ➝ $30.00Low
11/3/2022Raymond JamesLower TargetOutperform$45.00 ➝ $40.00Low
11/2/2022Robert W. BairdUpgradeNeutral ➝ Outperform$41.00N/A
10/13/2022BarclaysLower Target$33.00Low
8/24/2022BenchmarkBoost TargetBuy$44.00 ➝ $46.00Low
8/17/2022Credit Suisse GroupBoost TargetUnderperform$35.00 ➝ $38.00Low
8/17/2022Canaccord Genuity GroupBoost Target$44.00 ➝ $46.00Low
5/4/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$47.00 ➝ $44.00Low
5/4/2022Piper SandlerUpgradeNeutral ➝ Overweight$39.00 ➝ $45.00High
5/3/2022SVB LeerinkReiterated RatingOutperformLow
4/13/2022GuggenheimInitiated CoverageNeutralLow
4/1/2022Credit Suisse GroupInitiated CoverageUnderperform$35.00Low
11/18/2021BarclaysBoost TargetUnderweight$34.00 ➝ $36.00Medium
11/3/2021Piper SandlerBoost TargetNeutral$31.00 ➝ $39.00High
8/19/2021Raymond JamesBoost TargetOutperform$39.00 ➝ $45.00Low
8/18/2021SVB LeerinkBoost TargetOutperform$44.00 ➝ $46.00High
5/28/2021BarclaysDowngradeOverweight ➝ Underweight$42.00 ➝ $34.00High
5/6/2021Robert W. BairdReiterated RatingHoldMedium
5/4/2021Piper SandlerLower Target$36.00 ➝ $31.00Medium
2/4/2021Craig HallumBoost TargetHold$33.00 ➝ $38.00Medium
2/4/2021Piper SandlerBoost TargetNeutral$32.00 ➝ $36.00Medium
2/3/2021Raymond JamesBoost TargetOutperform$37.00 ➝ $39.00Low
2/3/2021SVB LeerinkBoost TargetOutperform$39.00 ➝ $44.00Low
2/3/2021BenchmarkUpgradeHold ➝ Buy$42.00Low
1/19/2021Bank of AmericaDowngradeBuy ➝ Underperform$41.00 ➝ $36.00High
1/15/2021Credit Suisse GroupDowngradeNeutral ➝ Underperform$35.00Low
1/8/2021Jefferies Financial GroupDowngradeBuy ➝ Hold$40.00Low
12/8/2020Berenberg BankInitiated CoverageBuy$42.00Low
11/3/2020Piper SandlerBoost TargetNeutral$31.00 ➝ $32.00High
10/7/2020Raymond JamesReiterated RatingBuyMedium
8/31/2020GuggenheimUpgradeNeutral ➝ Buy$37.00Medium
8/27/2020UBS GroupLower TargetNeutral$33.00 ➝ $32.00Low
8/26/2020SVB LeerinkLower TargetOutperform$42.00 ➝ $39.00Medium
8/26/2020Raymond JamesLower TargetOutperform$40.00 ➝ $37.00Medium
8/26/2020BenchmarkDowngradeBuy ➝ HoldMedium
8/12/2020Credit Suisse GroupLower TargetNeutral$37.00 ➝ $35.00High
5/12/2020SunTrust BanksBoost TargetHold$30.00 ➝ $32.00Medium
5/11/2020Cantor FitzgeraldInitiated CoverageOverweight$42.00Medium
5/6/2020Robert W. BairdBoost TargetNeutral$34.00 ➝ $36.00Low
5/6/2020UBS GroupLower TargetNeutral$35.00 ➝ $33.00Medium
4/13/2020SVB LeerinkInitiated CoverageOutperform$42.00High
3/26/2020SunTrust BanksLower TargetHold$38.00 ➝ $30.00High
2/11/2020Credit Suisse GroupLower TargetNeutral$38.00 ➝ $37.00Low
2/5/2020Robert W. BairdLower TargetNeutral$41.00 ➝ $36.00Medium
2/5/2020BenchmarkReiterated RatingBuy$46.00 ➝ $43.00Medium
2/4/2020Piper SandlerReiterated RatingHoldMedium
1/19/2020BarclaysReiterated RatingBuy$44.00Low
11/11/2019Robert W. BairdDowngradeOutperform ➝ Neutral$41.00Low
11/11/2019Evercore ISIReiterated RatingHoldLow
10/31/2019UBS GroupDowngradeBuy ➝ Neutral$44.00 ➝ $38.00High
9/26/2019Jefferies Financial GroupSet TargetBuy$43.00Low
9/26/2019Robert W. BairdSet TargetBuy$46.00Low
8/22/2019Piper Sandler CompaniesReiterated RatingHoldHigh
8/13/2019Credit Suisse GroupReiterated RatingOutperform ➝ Neutral$43.00 ➝ $42.00Low
6/18/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$41.00Low
5/2/2019CitigroupUpgradeNeutral ➝ Buy$45.00Medium
(Data available from 4/19/2019 forward)

News Sentiment Rating

0.78 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 13 very positive mentions
  • 14 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 3 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 6 very positive mentions
  • 13 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
Mentions as of
11/21/2023
  • 7 very positive mentions
  • 18 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 7 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
1/20/2024
  • 23 very positive mentions
  • 22 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 19 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 19 very positive mentions
  • 19 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 19 very positive mentions
  • 19 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Premier logo
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; and STOCKD, an e-commerce platform, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is based in Charlotte, North Carolina.
Read More

Today's Range

Now: $21.05
Low: $20.81
High: $21.06

50 Day Range

MA: $21.30
Low: $20.64
High: $22.10

52 Week Range

Now: $21.05
Low: $18.89
High: $33.58

Volume

73,745 shs

Average Volume

1,558,951 shs

Market Capitalization

$2.52 billion

P/E Ratio

15.14

Dividend Yield

4.07%

Beta

0.38

Frequently Asked Questions

What sell-side analysts currently cover shares of Premier?

The following Wall Street analysts have issued research reports on Premier in the last year: Bank of America Co., Barclays PLC, Benchmark Co., Canaccord Genuity Group Inc., Credit Suisse Group AG, JPMorgan Chase & Co., Leerink Partnrs, Piper Sandler, Raymond James, Robert W. Baird, StockNews.com, SVB Leerink LLC, and UBS Group AG.
View the latest analyst ratings for PINC.

What is the current price target for Premier?

10 Wall Street analysts have set twelve-month price targets for Premier in the last year. Their average twelve-month price target is $25.15, suggesting a possible upside of 19.5%. Benchmark Co. has the highest price target set, predicting PINC will reach $30.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $21.00 for Premier in the next year.
View the latest price targets for PINC.

What is the current consensus analyst rating for Premier?

Premier currently has 1 sell rating, 9 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PINC, but not buy more shares or sell existing shares.
View the latest ratings for PINC.

What other companies compete with Premier?

Other companies that are similar to Premier include Summit Therapeutics, Evotec, Integra LifeSciences, CG Oncology and Corcept Therapeutics. Learn More about companies similar to Premier.

How do I contact Premier's investor relations team?

Premier's physical mailing address is 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The company's listed phone number is (704) 357-0022 and its investor relations email address is [email protected]. The official website for Premier is www.premierinc.com. Learn More about contacing Premier investor relations.